Skip to main content

Table 1 Annual net economic benefit in Canada: Nurse time and compensation per patient switched from hospital-based IVIg to home-based SCIg

From: Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada

 

Year 1

Subsequent years

Home-based SCIg Therapy

  

  Nurse hours: training

6

0

  Nurse hours: monitoring

6

6

  Nurse compensation, C$

691

345

Hospital-based IVIg therapy

  

  Nurse Hours: IV administration and monitoring

57.2

57.2

  Nurse Compensation, C$

3,294

3,294

Net economic benefit (IVIg – SCIg)

  

  Savings: nurse hours

45.2

51.2

  Savings: nurse compensation, C$

2,603

2,948